217 related articles for article (PubMed ID: 14679015)
1. Sequential action of phase I and II enzymes cytochrome p450 1B1 and glutathione S-transferase P1 in mammary estrogen metabolism.
Hachey DL; Dawling S; Roodi N; Parl FF
Cancer Res; 2003 Dec; 63(23):8492-9. PubMed ID: 14679015
[TBL] [Abstract][Full Text] [Related]
2. In vitro model of mammary estrogen metabolism: structural and kinetic differences between catechol estrogens 2- and 4-hydroxyestradiol.
Dawling S; Hachey DL; Roodi N; Parl FF
Chem Res Toxicol; 2004 Sep; 17(9):1258-64. PubMed ID: 15377160
[TBL] [Abstract][Full Text] [Related]
3. Cytochrome P450 isoforms catalyze formation of catechol estrogen quinones that react with DNA.
Zhang Y; Gaikwad NW; Olson K; Zahid M; Cavalieri EL; Rogan EG
Metabolism; 2007 Jul; 56(7):887-94. PubMed ID: 17570247
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450 1B1-mediated estrogen metabolism results in estrogen-deoxyribonucleoside adduct formation.
Belous AR; Hachey DL; Dawling S; Roodi N; Parl FF
Cancer Res; 2007 Jan; 67(2):812-7. PubMed ID: 17234793
[TBL] [Abstract][Full Text] [Related]
5. Estrogens, enzyme variants, and breast cancer: a risk model.
Crooke PS; Ritchie MD; Hachey DL; Dawling S; Roodi N; Parl FF
Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1620-9. PubMed ID: 16985022
[TBL] [Abstract][Full Text] [Related]
6. Spectroscopic characterization of the 4-hydroxy catechol estrogen quinones-derived GSH and N-acetylated Cys conjugates.
Jankowiak R; Markushin Y; Cavalieri EL; Small GJ
Chem Res Toxicol; 2003 Mar; 16(3):304-11. PubMed ID: 12641430
[TBL] [Abstract][Full Text] [Related]
7. 17 beta-estradiol metabolism by hamster hepatic microsomes: comparison of catechol estrogen O-methylation with catechol estrogen oxidation and glutathione conjugation.
Butterworth M; Lau SS; Monks TJ
Chem Res Toxicol; 1996 Jun; 9(4):793-9. PubMed ID: 8831825
[TBL] [Abstract][Full Text] [Related]
8. Bioactivation of estrone and its catechol metabolites to quinoid-glutathione conjugates in rat liver microsomes.
Iverson SL; Shen L; Anlar N; Bolton JL
Chem Res Toxicol; 1996 Mar; 9(2):492-9. PubMed ID: 8839054
[TBL] [Abstract][Full Text] [Related]
9. Methoxyestrogens exert feedback inhibition on cytochrome P450 1A1 and 1B1.
Dawling S; Roodi N; Parl FF
Cancer Res; 2003 Jun; 63(12):3127-32. PubMed ID: 12810639
[TBL] [Abstract][Full Text] [Related]
10. Covalent binding of catechol estrogens to glutathione catalyzed by horseradish peroxidase, lactoperoxidase, or rat liver microsomes.
Cao K; Devanesan PD; Ramanathan R; Gross ML; Rogan EG; Cavalieri EL
Chem Res Toxicol; 1998 Aug; 11(8):917-24. PubMed ID: 9705754
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol inhibits TCDD-induced expression of CYP1A1 and CYP1B1 and catechol estrogen-mediated oxidative DNA damage in cultured human mammary epithelial cells.
Chen ZH; Hurh YJ; Na HK; Kim JH; Chun YJ; Kim DH; Kang KS; Cho MH; Surh YJ
Carcinogenesis; 2004 Oct; 25(10):2005-13. PubMed ID: 15142886
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of glutathione S-transferase activity by the quinoid metabolites of equine estrogens.
Chang M; Zhang F; Shen L; Pauss N; Alam I; van Breemen RB; Blond SY; Bolton JL
Chem Res Toxicol; 1998 Jul; 11(7):758-65. PubMed ID: 9671538
[TBL] [Abstract][Full Text] [Related]
13. Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity.
Hanna IH; Dawling S; Roodi N; Guengerich FP; Parl FF
Cancer Res; 2000 Jul; 60(13):3440-4. PubMed ID: 10910054
[TBL] [Abstract][Full Text] [Related]
14. p-Quinone methides are the major decomposition products of catechol estrogen o-quinones.
Bolton JL; Shen L
Carcinogenesis; 1996 May; 17(5):925-9. PubMed ID: 8640939
[TBL] [Abstract][Full Text] [Related]
15. One-electron oxidation of diclofenac by human cytochrome P450s as a potential bioactivation mechanism for formation of 2'-(glutathion-S-yl)-deschloro-diclofenac.
Boerma JS; Vermeulen NP; Commandeur JN
Chem Biol Interact; 2014 Jan; 207():32-40. PubMed ID: 24246759
[TBL] [Abstract][Full Text] [Related]
16. A methoxyflavonoid, chrysoeriol, selectively inhibits the formation of a carcinogenic estrogen metabolite in MCF-7 breast cancer cells.
Takemura H; Uchiyama H; Ohura T; Sakakibara H; Kuruto R; Amagai T; Shimoi K
J Steroid Biochem Mol Biol; 2010 Jan; 118(1-2):70-6. PubMed ID: 19833205
[TBL] [Abstract][Full Text] [Related]
17. Is bisphenol A a weak carcinogen like the natural estrogens and diethylstilbestrol?
Cavalieri EL; Rogan EG
IUBMB Life; 2010 Oct; 62(10):746-51. PubMed ID: 20945454
[TBL] [Abstract][Full Text] [Related]
18. Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms.
Dawling S; Roodi N; Mernaugh RL; Wang X; Parl FF
Cancer Res; 2001 Sep; 61(18):6716-22. PubMed ID: 11559542
[TBL] [Abstract][Full Text] [Related]
19. Catechol estrogen conjugates and DNA adducts in the kidney of male Syrian golden hamsters treated with 4-hydroxyestradiol: potential biomarkers for estrogen-initiated cancer.
Devanesan P; Todorovic R; Zhao J; Gross ML; Rogan EG; Cavalieri EL
Carcinogenesis; 2001 Mar; 22(3):489-97. PubMed ID: 11238191
[TBL] [Abstract][Full Text] [Related]
20. Preferential induction of cytochrome P450 1A1 over cytochrome P450 1B1 in human breast epithelial cells following exposure to quercetin.
Mense SM; Chhabra J; Bhat HK
J Steroid Biochem Mol Biol; 2008 May; 110(1-2):157-62. PubMed ID: 18456490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
